Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00412035 · ClinicalTrials.gov registry record · Phase 3
Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery
A Phase 3 study, sponsored by Shriners Hospitals for Children.
- Completed
- Registry status
- Phase 3
- Development phase
- 125
- Enrollment target
NCT00412035 is a Phase 3 study that has completed, run by Shriners Hospitals for Children. The registered enrollment target is 125 participants.
The verdict
NCT00412035, a Phase 3 study, has completed, sponsored by Shriners Hospitals for Children.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 125 participants
- Enrollment target
Study Summary
The purpose of this six site multi-center study is to determine if BTX-A can alleviate the post-operative pain and improve the functional and quality of life outcomes of children with limb length discrepancy or angular deformity undergoing limb lengthening or deformity correction.
Interventions
- DRUG Botulinum toxin A injection
- DRUG saline injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2007-01 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00412035
The ClinicalTrials.gov registry entry for NCT00412035 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shriners Hospitals for Children, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botulinum toxin A injection is the first listed.
NCT00412035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00412035 about?
NCT00412035 is a clinical study titled "Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery". The purpose of this six site multi-center study is to determine if BTX-A can alleviate the post-operative pain and improve the functional and quality of life outcomes of children with limb length discrepancy or angular deformity undergoing limb lengthening or deformity correction.
What is the current status of trial NCT00412035?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 125 participants. The study started on 2007-01. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00412035?
The interventions under investigation include: Botulinum toxin A injection (DRUG), saline injection (DRUG).
Who is sponsoring clinical trial NCT00412035?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.